≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of accessory sinuses, including Hilmo

Endpoint Browser PheWeb

C3_ACCESSORY_SINUS_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C31
  • Hospital discharge: ICD-9 — 160
  • Hospital discharge: ICD-8 — 160
  • Cause of death: ICD-10 — C31
  • Cause of death: ICD-9 — 160
  • Cause of death: ICD-8 — 160
  • Cause of death: excluded ICD-9 — 160[0-1]
  • Cause of death: excluded ICD-8 — 160[0-1]
  • Cancer registry: Topography ICD-O-3 — C31
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

193

4. Check minimum number of events

None

193

5. Include endpoints

None

193

6. Filter based on genotype QC (FinnGen only)

171

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 171 65 106
Unadjusted period prevalence (%) 0.04 0.02 0.05
Median age at first event (years) 63.81 61.31 65.35

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
177
Matched controls
1770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
71.9
64
*
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
+∞
59.8
54
*
XX3DW
NOMESCO Finland
Time consuming IT work
18.1
46.6
41
29
H02AB02
ATC
dexamethasone; systemic
79.2
42.8
47
8
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
42.4
39
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
11.5
40.8
49
57
WF002
NOMESCO Finland
Radical radiotherapy
474.3
39.7
38
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.2
37.0
63
112
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
33.4
31
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
33.4
31
*
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
+∞
31.2
29
*
N02AA05
ATC
oxycodone; systemic
6.4
29.9
66
150
WZC00
NOMESCO Finland
Treatment plan or consultation
5.5
28.5
88
269
C31.9
ICD-10 Finland
Malignant neoplasm: Accessory sinus, unspecified
+∞
27.8
26
*
A04AA02
ATC
granisetron; systemic, transdermal
316.4
27.5
27
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
316.4
27.5
27
*
Z51.5
ICD-10 Finland
Palliative care
10.3
26.3
32
37
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
25.6
24
*
C31.1
ICD-10 Finland
Malignant neoplasm: Ethmoidal sinus
+∞
24.5
23
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
262.6
23.2
23
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
45.1
22.5
27
7
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
21.3
20
*
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
+∞
21.3
20
*
UDM02
NOMESCO Finland
Sinoscopy
25.3
20.2
28
13
8070/3-C31.0
ICD-O-3
Squamous cell carcinoma, NOS, of maxillary sinus
+∞
20.2
19
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
20.2
19
*
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
8.7
19.7
27
36
A04AA01
ATC
ondansetron; systemic, rectal
24.2
19.3
27
13
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
+∞
19.1
18
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
28.8
18.8
25
10
DHA10
NOMESCO Finland
Biopsy of cavity of nose
32.7
17.9
23
8
JN4BD
NOMESCO Finland
Extensive body CT
8.4
17.9
25
34
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
16.9
16
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
16.9
16
*
L03AA13
ATC
pegfilgrastim; parenteral
186.9
16.8
17
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
66.3
16.1
18
*
R04.0
ICD-10 Finland
Epistaxis
5.2
15.0
35
80
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
87.6
14.8
16
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
14.8
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.8
14
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
39.8
14.7
18
5
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
162.9
14.7
15
*
A07AA02
ATC
nystatin; oral
6.6
13.9
24
41
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
81.2
13.8
15
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
20.3
13.7
20
11
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
+∞
13.7
13
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
13.7
13
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
151.1
13.6
14
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
43.7
13.4
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
139.5
12.6
13
*
L03AA02
ATC
filgrastim; parenteral
139.5
12.6
13
*
DPA30
NOMESCO Finland
Sphenotomy
40.7
12.4
15
*
WZC30
NOMESCO Finland
Teaching
4.2
12.2
38
109
EBB10
NOMESCO Finland
Insertion of dental implant
32.5
11.8
15
5
ZX090
NOMESCO Finland
Other technic of radiotherapy
69.7
11.8
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
69.7
11.8
13
*
A04AD12
ATC
aprepitant; systemic
+∞
11.6
11
*
EEB10
NOMESCO Finland
Maxillectomy
+∞
11.6
11
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.6
11
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
11.6
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
128.0
11.6
12
*
EEB00
NOMESCO Finland
Partial excision of maxilla
128.0
11.6
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.0
11.4
19
15
GBB00
NOMESCO Finland
Tracheostomy
21.8
11.4
16
8
WX402
NOMESCO Finland
General anaesthesia
3.5
11.2
46
160
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.9
10.9
37
113
D70.82
ICD-10 Finland
Drug-induced neutropenia
116.6
10.5
11
*
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
+∞
10.5
10
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
10.5
10
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
10.5
10
*
SAA03
NOMESCO Finland
Extended examination of mouth
2.8
10.2
79
394
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
8.2
10.1
22
30
ZXE40
NOMESCO Finland
More than seven and less than nine hours
27.9
10.0
13
5
GD6AD
NOMESCO Finland
CT of chest and neck
58.3
9.8
11
*
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
58.3
9.8
11
*
SBB10
NOMESCO Finland
Dental impressions
5.0
9.6
22
49
ZX120
NOMESCO Finland
Intravenous
5.2
9.6
21
45
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
11.6
9.5
17
16
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
23.2
9.5
13
6
116
Kela drug reimbursment
Prostate cancer
+∞
9.5
9
*
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
+∞
9.5
9
*
A79
ICPC
Malignancy NOS
+∞
9.5
9
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
9.5
9
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.2
9.2
20
27
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.9
9.1
29
84
ZXC95
NOMESCO Finland
Use of surgical navigator
25.6
9.0
12
5
WW500
NOMESCO Finland
Blood transfusion
10.9
8.7
16
16
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.7
8.7
21
49
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
9.3
8.5
17
20
EP1AE
NOMESCO Finland
Neck ultrasound examination
7.7
8.5
19
27
ZZC00
NOMESCO Finland
Graft of fascia
94.4
8.5
9
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
94.4
8.5
9
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
8.4
8
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
+∞
8.4
8
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
8.4
8
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
8.4
32
105
EBB15
NOMESCO Finland
Insertion of dental implant abutment
35.1
8.2
10
*
SPF20
NOMESCO Finland
Temporary relining of dentures
47.1
7.8
9
*
DHB40
NOMESCO Finland
Conchotomy
47.1
7.8
9
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
47.1
7.8
9
*
R4190
NOMESCO Finland
Nutritional therapy
12.6
7.7
13
11
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
7.5
49
219
DPB00
NOMESCO Finland
Partial excision of frontal sinus
83.4
7.5
8
*
L02AE02
ATC
leuprorelin; implant, parenteral
83.4
7.5
8
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
7.5
44
186
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
10.0
7.4
14
15
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
7.3
7
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
7.3
7
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
C31.3
ICD-10 Finland
Malignant neoplasm: Sphenoidal sinus
+∞
7.3
7
*
DKW40
NOMESCO Finland
Ligature of artery of internal nose
+∞
7.3
7
*
ZZR00
NOMESCO Finland
Flap of skin
+∞
7.3
7
*
DJB10
NOMESCO Finland
Excision of septum of nose
+∞
7.3
7
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
7.3
7
*
1600A
ICD-9 Finland
Malignant neoplasm of nasal cavities, middle ear and accessory sinuses, Nasal cavities
+∞
7.3
7
*
8720/3-C30.0
ICD-O-3
Malignant melanoma, NOS, of nasal cavity
+∞
7.3
7
*
JN4AD
NOMESCO Finland
Body CT examination
4.2
7.2
20
52
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.8
7.2
12
10
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
10.7
7.2
13
13
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
14.5
7.0
11
8
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
6.8
27
90
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
17.5
6.8
10
6
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
41.7
6.8
8
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.3
6.7
27
91
EBA15
NOMESCO Finland
Extraction of multiple teeth
6.7
6.6
16
26
ZXE00
NOMESCO Finland
One hour or less
2.3
6.5
71
399
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.4
6.5
16
27
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
72.3
6.5
7
*
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
72.3
6.5
7
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.3
6.4
76
442
XW000
NOMESCO Finland
Bone marrow biopsy
9.8
6.4
12
13
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
18.9
6.3
9
5
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
+∞
6.3
6
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
+∞
6.3
6
*
EEB20
NOMESCO Finland
Hemimaxillectomy
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
6.3
6
*
8720/3-C31.0
ICD-O-3
Malignant melanoma, NOS, of maxillary sinus
+∞
6.3
6
*
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
6.3
6
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
6.3
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
+∞
6.3
6
*
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
+∞
6.3
6
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.9
6.2
19
53
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.6
6.2
17
33
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
13.1
6.2
10
8
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
5.8
6.0
16
30

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
56
33
24.36
70.89
1.9
1.3
—
—
—
0
0
89
402
3.44
14.77
4.3
1.6
—
—
—
0
0
45
165
3.32
9.97
2.7
1.8
—
—
—
0
0
32
95
3.89
9.73
2.7
3.7
0.35
0.14
%
0.44
23
22
32
99
3.72
9.15
2.5
2.0
0.24
0.20
g/l
1.64
32
81
32
100
3.69
9.01
2.8
3.6
1.41
0.56
%
0.87
22
27
31
95
3.74
8.98
2.4
3.7
1.40
0.22
%
1.91
21
27
30
94
3.64
8.40
1.4
1.1
—
—
—
0
0
95
569
2.45
7.86
6.6
3.5
32.84
35.57
g/l
3.67
88
520
45
196
2.74
7.19
2.7
1.7
—
—
—
0
0
70
384
2.36
6.85
3.7
2.0
—
—
—
0
0
105
685
2.31
6.81
10.8
6.1
1.21
1.21
mmol/l
0.02
87
597
90
558
2.25
6.51
4.2
2.4
—
—
estimate
—
0
0
6
0
+∞
6.28
5.8
0.0
0.37
—
umol/l
—
6
0
38
162
2.71
6.28
8.3
7.5
0.93
1.26
mmol/l
0.15
30
138
75
440
2.22
6.12
6.5
2.0
2.36
2.35
mmol/l
0.31
70
378
22
69
3.50
6.11
1.7
1.5
—
—
—
0
0
93
597
2.18
6.03
8.8
5.7
1.20
1.21
mmol/l
0.29
84
540
27
99
3.04
5.85
2.7
3.7
0.06
0.00
%
0.48
17
19
104
704
2.16
5.82
19.7
6.1
3.85
4.20
e9/l
0.92
95
611
38
169
2.59
5.75
8.3
7.3
7.41
7.42
ph
0.35
21
100
14
27
5.54
5.20
2.5
3.1
1.14
1.96
mg/l
2.87
14
21
69
414
2.09
5.14
7.4
5.2
—
—
—
0
0
11
16
7.25
5.03
1.2
1.3
—
—
—
0
0
35
172
2.29
4.22
1.6
1.5
—
—
—
0
0
62
382
1.96
4.15
6.3
3.8
—
—
—
0
0
95
675
1.88
4.11
8.7
15.6
1.19
1.33
inr
1.91
80
561
53
311
2.01
4.06
6.4
3.1
86.45
86.23
%
0.03
53
301
7
7
10.34
4.04
1.1
1.0
—
—
—
0
0
9
14
6.71
4.03
1.9
3.8
—
—
—
0
0
104
1288
0.53
3.93
6.1
5.3
6.04
6.08
mmol/l
0.14
94
1170
107
800
1.85
3.84
7.5
4.5
6.87
6.84
mmol/l
0.07
100
756
105
1292
0.54
3.78
5.0
5.5
4.68
4.48
mmol/l
0.90
98
1200
33
573
0.48
3.63
1.8
2.0
1.25
1.31
mmol/l
0.23
24
479
108
1313
0.54
3.62
5.6
6.3
2.73
2.59
mmol/l
0.60
99
1212
105
1286
0.55
3.59
5.1
5.4
1.44
1.43
mmol/l
0.05
97
1186
7
9
8.04
3.59
1.3
1.1
—
—
—
0
0
7
9
8.04
3.59
1.9
1.6
19.57
21.52
ng/l
—
7
9
11
26
4.44
3.57
5.2
2.2
25.45
9.86
u/ml
1.22
11
16
62
401
1.84
3.49
6.1
3.3
7.40
7.40
ph
0.64
50
279
52
321
1.88
3.37
1.6
1.3
—
—
—
0
0
26
124
2.29
3.34
1.7
1.4
—
—
—
0
0
91
668
1.75
3.29
7.7
5.2
0.04
0.04
e9/l
1.29
81
575
90
661
1.74
3.23
7.7
5.2
0.58
0.59
e9/l
0.22
79
567
27
134
2.20
3.16
1.6
1.4
—
—
—
0
0
92
683
1.72
3.15
8.0
5.4
0.19
0.20
e9/l
0.20
83
591
91
674
1.72
3.14
7.7
5.3
1.57
1.80
e9/l
2.04
82
593
19
81
2.51
3.11
2.5
1.9
9.86
10.99
g/l
0.57
19
75
102
1232
0.59
2.84
4.7
4.6
1.30
1.29
mmol/l
0.08
91
1129
29
156
2.03
2.77
1.8
1.5
—
—
—
0
0
23
115
2.15
2.65
9.0
8.0
—
—
—
0
0
40
244
1.83
2.65
3.2
2.8
527.27
545.49
mosm/kgh2o
0.20
33
207
106
1259
0.61
2.61
6.9
7.1
40.00
40.34
mmol/mol
0.14
96
1172
5
7
7.31
2.56
2.2
1.6
16.67
15.54
ug/l
—
5
7
26
140
2.00
2.48
1.7
1.9
66.22
62.58
e9/l
0.20
19
103
10
32
3.25
2.48
1.3
1.2
—
—
—
0
0
8
24
3.44
2.21
3.4
2.0
63.63
59.86
%
—
8
24
52
359
1.64
2.20
14.8
4.5
—
—
—
0
0
6
14
4.40
2.17
1.7
1.0
—
—
—
0
0
11
44
2.60
2.05
4.4
1.2
68.62
33.57
mg/l
0.46
11
39
6
16
3.84
1.95
1.3
3.8
—
—
—
0
0
7
22
3.27
1.90
1.4
1.1
—
—
—
0
0
6
17
3.61
1.85
3.2
2.1
2.66
5.07
e9/l
—
6
17
59
437
1.53
1.82
3.1
2.9
17.47
220.52
e6/l
0.76
47
334
51
368
1.54
1.76
2.8
2.9
0.27
0.40
e6/l
0.36
40
263
43
300
1.57
1.72
2.9
2.5
5.58
4.83
e6/l
0.15
37
274
7
25
2.87
1.66
1.6
1.1
—
—
—
0
0
5
14
3.64
1.62
1.8
1.1
—
—
—
0
0
10
44
2.35
1.58
4.7
1.2
29.75
50.56
mg/l
—
10
39
39
536
0.65
1.56
6.5
4.2
7.21
7.01
mg/mmol
0.02
27
358
38
523
0.65
1.53
5.0
3.5
38.37
46.15
mg/l
0.17
28
362
40
542
0.66
1.49
4.9
3.4
8.60
7.90
mmol/l
0.29
34
457
108
1222
0.70
1.45
7.4
5.0
2.36
1.95
mu/l
1.32
97
1107
50
375
1.46
1.42
2.0
2.2
2.88
2.84
mg/l
0.04
41
316
15
84
1.86
1.31
3.9
5.3
—
—
—
0
0
6
24
2.55
1.31
3.3
1.4
—
—
—
0
0
5
18
2.83
1.29
1.0
1.3
61.80
60.58
pmol/l
—
5
18
8
35
2.35
1.28
1.6
1.2
68.00
5.48
e6/l
—
8
27
8
36
2.28
1.26
1.6
1.3
4649.13
3438.86
e6/l
—
8
28
20
125
1.68
1.24
2.2
2.4
0.49
0.44
e6/l
0.07
20
116
8
37
2.22
1.23
2.5
4.2
—
—
—
0
0
5
20
2.54
1.16
2.4
2.3
—
—
—
0
0
17
105
1.68
1.11
3.4
2.0
66.46
67.65
g/l
0.32
17
97
68
562
1.34
1.07
18.1
9.7
0.00
0.00
e9/l
0.91
61
458
15
91
1.71
1.04
3.1
1.5
—
—
—
0
0
5
22
2.31
1.04
1.4
1.0
—
—
—
0
0
9
50
1.84
0.98
1.4
1.2
—
—
—
0
0
38
290
1.40
0.98
3.3
4.5
147.28
375.99
ng/l
0.63
32
234
17
111
1.59
0.91
1.5
1.5
—
—
—
0
0
59
488
1.31
0.91
3.8
3.6
11.21
80.77
e6/l
3.07
47
347
15
225
0.64
0.89
1.5
1.3
13.24
10.90
u/ml
—
5
88
25
337
0.70
0.88
3.4
2.8
0.68
0.80
ug/l
0.42
17
218
50
603
0.76
0.86
5.3
4.2
1.74
1.98
ug/l
0.52
45
533
95
842
1.28
0.85
4.1
4.5
67.60
281.79
e6/l
—
5
14
56
660
0.78
0.80
2.3
2.1
86.94
96.94
pmol/l
1.02
37
344
46
555
0.77
0.78
3.5
3.5
6.33
6.18
ph
0.46
33
310
28
211
1.39
0.78
2.3
2.7
1.76
2.61
e6/l
0.34
19
103
36
285
1.33
0.75
5.8
4.1
—
—
—
0
0
9
56
1.64
0.73
2.0
3.2
26.40
24.83
mmol/l
—
9
51
36
286
1.32
0.73
1.8
1.6
1.12
1.15
mg/l
0.04
29
220
5
26
1.95
0.71
1.4
1.1
—
—
—
0
0
13
85
1.57
0.71
1.4
1.3
107.32
622.14
u/ml
0.94
13
80
40
482
0.78
0.67
4.0
3.6
—
—
—
0
0
21
274
0.73
0.62
1.2
1.3
0.83
0.97
u/ml
—
7
90
14
97
1.48
0.61
8.4
3.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
7
114
0.60
0.60
2.4
1.5
—
—
—
0
0
22
168
1.35
0.58
1.0
1.2
—
—
—
0
0
5
86
0.57
0.58
1.2
1.3
—
42.38
—
0
8
5
89
0.55
0.57
1.2
1.3
—
—
—
0
0
29
232
1.30
0.57
1.7
1.3
2.43
2.73
g/l
0.47
23
143
8
55
1.48
0.57
1.3
1.5
—
—
—
0
0
32
261
1.28
0.55
1.6
1.8
1015.42
1147.79
nmol/l
0.37
24
206
9
62
1.48
0.54
1.2
1.4
—
—
—
0
0
12
85
1.44
0.48
1.3
1.2
—
—
—
0
0
5
85
0.58
0.46
1.2
1.2
—
—
—
0
0
64
708
0.85
0.44
4.3
3.8
0.00
0.00
estimate
-0.00
17
131
13
172
0.74
0.43
1.7
1.3
—
732.31
—
0
39
0
15
0.00
0.41
0.0
2.5
—
577.38
—
0
8
0
16
0.00
0.41
0.0
2.1
—
-0.90
—
0
16
0
18
0.00
0.40
0.0
1.6
—
0.21
—
0
11
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
64
702
0.86
0.39
4.3
3.8
0.00
0.00
estimate
-0.00
17
138
129
1344
0.85
0.38
26.1
13.2
—
—
—
0
0
10
74
1.37
0.33
1.8
3.0
—
—
—
0
0
35
307
1.17
0.32
2.2
1.9
336.97
401.75
pmol/l
1.53
30
255
64
692
0.88
0.31
4.2
3.8
0.00
0.00
estimate
-0.00
15
136
15
121
1.26
0.29
1.8
1.3
—
—
—
0
0
103
1080
0.89
0.29
35.3
18.7
330.44
332.31
g/l
1.17
103
1070
13
103
1.28
0.29
1.8
2.8
7.43
7.42
ph
0.33
13
84
36
402
0.87
0.27
5.2
3.6
0.00
0.00
estimate
-0.00
16
123
13
106
1.24
0.24
1.9
2.8
5.09
4.92
kpa
0.49
13
101
132
1358
0.89
0.23
33.9
18.2
3.96
4.01
mmol/l
1.25
127
1311
42
383
1.13
0.23
3.0
3.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
254.27
—
0
11
0
10
0.00
0.21
0.0
1.0
—
81.10
—
0
10
0
10
0.00
0.21
0.0
1.1
—
147.20
—
0
10
0
10
0.00
0.21
0.0
11.3
—
0.62
—
0
10
0
12
0.00
0.21
0.0
2.0
—
11.01
—
0
12
0
13
0.00
0.21
0.0
3.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
273.00
—
0
9
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
33
361
0.89
0.19
2.5
3.2
—
0.20
—
0
10
133
1298
1.10
0.18
31.0
14.3
29.78
25.62
mg/l
0.76
126
1028
7
61
1.15
0.18
1.1
1.9
—
—
—
0
0
63
597
1.09
0.17
2.3
2.9
176.37
122.21
ug/l
0.88
57
555
58
610
0.93
0.15
3.8
4.1
31.27
100.68
ng/l
0.71
45
464
8
99
0.80
0.14
1.5
2.1
5.75
6.04
ph
—
8
71
18
163
1.12
0.11
4.2
2.8
7.39
7.39
ph
0.18
11
100
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
6
70
0.85
0.08
2.3
2.5
—
—
—
0
0
7
84
0.83
0.07
1.0
1.2
—
—
—
0
0
14
128
1.10
0.07
4.7
2.5
4.34
4.51
kpa
0.18
14
121
39
375
1.05
0.06
5.1
3.3
0.00
0.00
estimate
-0.00
14
105
52
536
0.96
0.06
4.3
3.7
0.00
0.00
estimate
-0.00
11
111
41
424
0.96
0.05
2.0
1.8
15.74
19.87
nmol/l
1.15
32
368
99
1001
0.98
0.03
6.3
3.9
14.32
14.90
pmol/l
1.39
91
920
103
1038
0.98
0.01
38.6
17.6
14.30
13.67
%
3.97
103
1020
32
316
1.02
0.00
2.7
4.2
1.02
1.02
kg/l
0.38
27
202
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
5
56
0.89
-0.00
1.0
1.5
—
5.42
—
0
16
8
84
0.95
-0.00
2.6
2.2
0.81
1.06
%
—
8
84
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
51.40
—
0
5
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
72.00
—
0
7
8
81
0.99
-0.00
2.6
2.2
0.56
0.60
%
—
8
81
0
5
0.00
-0.00
0.0
1.6
—
292.50
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.8
—
6.74
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_ACCESSORY_SINUS_WIDE – Malignant neoplasm of accessory sinuses, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).